Elly Barry

Technik-/Wissenschafts-/F&E-Leiter bei DAY ONE BIOPHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profil

Elly Barry is currently Co-Chairman of the Industry Relations Council at The Children's Oncology Group Foundation, Inc. and Chief Medical Officer at Day One Biopharmaceuticals, Inc. since 2024.
Formerly, Dr. Barry was Head of Pfizer Pediatric Oncology at Pfizer Inc. Education includes a doctorate from Yale School of Medicine and graduate studies at Harvard Medical School.

Aktive Positionen von Elly Barry

Unternehmen	Position	Beginn
DAY ONE BIOPHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.02.2024
The Children's Oncology Group Foundation, Inc.	Corporate Officer/Principal	-

Alle aktiven Positionen von Elly Barry

Ehemalige bekannte Positionen von Elly Barry

Unternehmen	Position	Ende
PFIZER INC.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Elly Barry im Detail an

Ausbildung von Elly Barry

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Elly Barry im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Children's Oncology Group Foundation, Inc.
Yale School of Medicine Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers	Health Technology